Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease

Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease

Background/Aims: In this retrospective study we aimed to compare the effect of tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in autosomal dominant polycystic kidney disease (ADPKD) patients with persistent gross hematuria. Methods: This is a retrospective study of...

Full description

Bibliographic Details
Main Authors: Qing Yao, Ming Wu, Jie Zhou, Meiyang Zhou, Dongping Chen, Lili Fu, Rongrong Bian, Xiaohong Xing, Lijun Sun, Xiaohong Hu, Lin Li, Bing Dai, Rudolf P. Wüthrich, Yiyi Ma, Chang-Lin Mei
Format: Article
Language:English
Published: Karger Publishers 2017-04-01
Series:Kidney & Blood Pressure Research
Subjects:
Persistent gross hematuria
Autosomal dominant polycystic kidney disease (ADPKD)
Tranexamic acid (TXA)
Etamsylate
Hyperfibrinolysis
Online Access:http://www.karger.com/Article/FullText/474961

Internet

http://www.karger.com/Article/FullText/474961

Similar Items